Conceptos Categóricos

Crónicas de autores

Cristina Ripoll *

Autora invitada por SIIC

El trabajo contribuye a establecer el papel del gradiente de presión venosa hepática en la supervivencia de pacientes con cirrosis

INFLUENCIA DEL GRADIENTE DE PRESION VENOSA HEPATICA EN LA PREDICCION DE LA SUPERVIVENCIA EN LA ERA MELD

El GPVH tiene un valor relevante en la explicación de la supervivencia teniendo en cuenta la puntuación MELD, y mejora la predicción de supervivencia para un determinado paciente; sin embargo, la adición del GPVH no mejora la capacidad discriminativa de las variables MELD.

*Cristina Ripoll
describe para SIIC los aspectos relevantes de su trabajo
INFLUENCE OF HEPATIC VENOUS PRESSURE GRADIENT ON THE PREDICTION OF SURVIVAL OF PATIENTS WITH CIRRHOSIS IN THE MELD ERA
Hepatology,
42(4):793-801 Oct, 2005

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Hospital General Universitario Gregorio Marañón, Madrid, España
Imprimir nota
Referencias bibliográficas
1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
3. McCaughan GW, Strasser SI. To MELD or not to MELD? Hepatology 2001;34:215-216.
4. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7:567-580.
5. Freeman RB, Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8:851-858.
6. Pagliaro L. MELD: the end of Child-Pugh classification? J Hepatol 2002; 36:141-142.
7. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40:897-903.
8. García-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5:419-424.
9. Feu F, García-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346:1056-1059.
10. Abraldes JG, Tarantino I, Turnes J, García-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37:902-908.
11. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, García-Pagan JC, Rodes J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117:626-631.
12. Bruix J, Castells A, Bosch J, Feu F, Fuster J, García-Pagan JC, Visa J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111:1018-1022.
13. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, Matloff DS, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology 1991; 13:902-912.
14. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345:647-655.
15. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52:134-139.
16. Salerno F, Borroni G, Moser P, Badalamenti S, Cassarà L, Maggi A, Fusini M et al. Survival and prognostic factos of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88:514-519.
17. Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó LI, Ventura PJ, Cardenas A et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34:46-52.
18. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, Morel I et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis:a 10-year prospective study. Gastroenterology 1996; 111:701-709.
19. Calès P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, Fermanian J et al. Gastroesophageal endoscopic features in cirrhosis. Gastroenterology 1990; 98:156-162.
20. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895.
21. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the study of the liver. J Hepatol 2001; 35(3):421-430.
22. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810.
23. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41(1):32-9.
24. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11(3):336-43.
25. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004; 39:280-282.
26. Valla D, Bercoff E, Menu Y, Bataille C, Lebrec D. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis. Gastroenterology 1984; 86:1400-1403.
27. Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagan JC, Bosch J. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999; 30:1393-1397.
28. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9:117-123.
29. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23:2109-2123.
30. Collet D. Modelling survival data in medical research. Florida: Chapman & Hall/CRC, 2003:58.
31. Andersen K, Abildstrom SZ, Rosthøj S. Competing risks as a multi-state model. Stat Methods Med Res 2002; 11:203-15.
32. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, Marrero JM et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40(4):793-801.
33. Villanueva C, Ortiz J, Miñana J, Soriano G, Sabat M, Boadas J, Balanzo J. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 2001; 121(1):110-7.
34. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, Rodes J, Gines P. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology 2005; 41:1282-9.
35. D’Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores. JAMA 2001; 286(2):180-187.
36. D’Amico G. Natural history of compensated cirrosis and varices. In: Boyer TD, Groszmann R, editors. Complications of cirrhosis: pathogenesis, consequences and therapy; Dallas, USA. 2001:118-123.
37. Rincón D, Bañares R, Alonso S, Salcedo M, Catalina MV, Barrio J, Poza A, Alvarez E. Prognositc value of hepatic venous pressure gradient in severe acute alcoholic hepatitis. J Hepatol 2003; 38(Suppl 2): 54A.


ua40317
-->